Actively Recruiting
Phase I Study of RO7830698 Evaluating Safety, Tolerability, and Immune Effects in Healthy Adults and Adults With Chronic Obstructive Pulmonary Disease Using Single and Multiple Dosing
Led by Hoffmann-La Roche · Updated on 2026-10-20
104
Participants Needed
1
Research Sites
36 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying the safety, tolerability, how the body processes pharmacokinetics, immune response immunogenicity, and effects pharmacodynamics of the drug RO7830698 in both healthy adults and adults with chronic obstructive pulmonary disease COPD. The trial includes healthy participants and those diagnosed with COPD to better understand how the drug behaves and its safety profile in these groups. Healthy participants will receive single doses of RO7830698 or a placebo, while participants with COPD will receive multiple doses of RO7830698 or placebo. The study is randomized and blinded, meaning neither participants nor investigators know who receives the drug or placebo. The trial is divided into Part 1 for single ascending doses and Part 2 for multiple ascending doses. During the study, participants will be closely monitored for adverse events and dose-limiting side effects for up to approximately 50 weeks in healthy volunteers and 44 weeks in COPD participants. Researchers will collect blood samples to measure drug levels and check for anti-drug antibodies. Participants will attend scheduled visits for safety assessments, and the study aims to evaluate the overall tolerability and immune response to RO7830698 over the treatment duration.
CONDITIONS
Brief Title
A Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
Research Team
R
Reference Study ID Number: WP46321 https://forpatients.roche.com/ No attachments to email below.
F
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here